BRN brainchip holdings ltd

0.00%

20.0¢

Ann: BrainChip Evaluates Redomiciling to US, page-173

First 173 Last

Share
Profile

Follow
LJD

1,290 Posts.

210

28/02/25

13:03

Post #: 78074883
Share

Originally posted by Fact Finder: ↑

From the first page of the announcement in the very first paragraph are printed in English the following words:

"Subject to the conditions described below, this timing would position the company for redomiciling by late 2025 or early 2026."

Unless I am wrong we all have about 8 to 10 months to decide what we might do and for Brainchip to make announcements about new deals, partnerships, IP sales etc as referred to by the CEO as being likely to take place in 2025.

In the last few days we have had the strongest possible confirmation of an epilepsy warning device based upon AKD1500 which has massive market potential.

This engagement with Onsor for Nexa came completely out of left field except for the fact that a previous CEO Mr. Dinardo predicted big things to come in the medical device area years ago. According to the information available Brainchip has been working with Onsor for a number of years to get to this point.

There is great scope given all the known engagements and the time that they have been in place for the CEO's prediction to come to fruition over the next 6 months or so.

As far as I personally am concerned I have plenty of time to get ready for the shift to the USA and plenty of time for the price of Brainchip's shares on the ASX to appreciate in line with the CEO's prediction of engagements coming to a successful conclusion in 2025.

For example as far as we know the US Airforce Research Laboratory subcontract is still under negotiation and assuming the subcontractor is revealed this could be a catalyst for positive price movement particularly if as I suspect it will be Lockheed Martin.

Remember there still has to be a vote of shareholders before this can move forward in any event.

As far as I am aware we do not yet have a large overseas institutional presence on the register so if the vote is successful it will mean that a lot of Australian investors with deep pockets have been convinced that this is the right move.

It is still three months approximately until the AGM the first opportunity for such a vote to take place so quite a bit of water still to pass under this bridge and a great deal more information to be provided and consumed before then.

My opinion only DYOR

Fact Finder

Expand

"Unless I am wrong we all have about 8 to 10 months to decide what we might do and for Brainchip to make announcements about new deals, partnerships, IP sales etc as referred to by the CEO as being likely to take place in 2025."

Have to disagree with you there, do you think that brn will make all the necessary arrangements first and then put it to a vote....please

BRN Price at posting: 20.8¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 173 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 20.0¢		Change 0.000(0.00%)		Mkt cap ! $405.0M

Open	High	Low	Value	Volume
20.5¢	21.0¢	20.0¢	$1.544M	7.615M

Buyers (Bids)

No.	Vol.	Price($)
3	61852	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	217258	9

View Market Depth

No.	Vol.	Price($)
2	32537	0.200
25	968327	0.195
38	1574473	0.190
40	1943108	0.185
65	1281316	0.180

Price($)	Vol.	No.
0.205	179258	6
0.210	1653584	26
0.215	846002	16
0.220	1267378	34
0.225	840448	18

Last trade - 16.20pm 27/06/2025 (20 minute delay)

BRN (ASX) Chart

Ann: BrainChip Evaluates Redomiciling to US, page-173

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: BrainChip Evaluates Redomiciling to US, page-173

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News